Marino Garcia
Director; Director, CEO AND PRESIDENT · 5 filings · Latest: Sep 11, 2026
AgomAb Therapeutics NV
Dianthus Therapeutics, Inc. /DE/
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DNTH | Marino Garcia | Director, CEO AND PRESIDENT | Aug 7, 2026 | Sale | $108.11 | 166,000 | $17.9M | 65,292 | |
DNTH | Marino Garcia | Director, CEO AND PRESIDENT | Aug 7, 2026 | Option Exercise | $8.44 | 166,000 | $1.4M | 231,292 | |
DNTH | MARINO GARCIA | — | Aug 7, 2026 | Proposed Sale | $109.92 | 40,000 | $4.4M | — | |
DNTH | MARINO GARCIA | — | Aug 7, 2026 | Proposed Sale | $108.09 | 126,000 | $13.6M | — | |
DNTH | Marino Garcia | Director, CEO AND PRESIDENT | Mar 16, 2026 | Option Exercise | $7.66 | 65,292 | $500.0K | 65,292 | |
DNTH | Marino Garcia | Director, CEO AND PRESIDENT | Mar 12, 2026 | Sale | $81.49 | 122,918 | $10.0M | 0 | |
DNTH | Marino Garcia | Director, CEO AND PRESIDENT | Mar 12, 2026 | Option Exercise | $6.70 | 122,918 | $823.6K | 122,918 | |
DNTH | MARINO GARCIA | — | Mar 12, 2026 | Proposed Sale | $85.84 | 122,918 | $10.6M | — |